Atlas Trials

Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

Clinical trial NCT06856967 · RECRUITING

Trial details

NCT number
NCT06856967
Sponsor
Meyer Children's Hospital IRCCS
Status
RECRUITING
Study type
OBSERVATIONAL
Respiratory Synctial Virus Infections
Start date
2024-12-04
Primary completion
2025-03-01
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.